IT1262929B - Impiego terapeutico del monosialodiesosil ganglioside gm3 e derivati come agenti anti-angiogenici - Google Patents

Impiego terapeutico del monosialodiesosil ganglioside gm3 e derivati come agenti anti-angiogenici

Info

Publication number
IT1262929B
IT1262929B ITMI920057A ITMI920057A IT1262929B IT 1262929 B IT1262929 B IT 1262929B IT MI920057 A ITMI920057 A IT MI920057A IT MI920057 A ITMI920057 A IT MI920057A IT 1262929 B IT1262929 B IT 1262929B
Authority
IT
Italy
Prior art keywords
monosilodihexosyl
angiogen
ganglioside
derivatives
agents
Prior art date
Application number
ITMI920057A
Other languages
English (en)
Inventor
Gino Toffano
Alberta Leon
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Priority to ITMI920057A priority Critical patent/IT1262929B/it
Publication of ITMI920057A0 publication Critical patent/ITMI920057A0/it
Publication of ITMI920057A1 publication Critical patent/ITMI920057A1/it
Application granted granted Critical
Publication of IT1262929B publication Critical patent/IT1262929B/it

Links

Landscapes

  • Saccharide Compounds (AREA)

Abstract

Viene descritto l'impiego del monosialodiesosilganglioside GM3, dei suoi derivati o dei loro sali farmacologicamente accettabili per la preparazione di composizioni farmaceutiche con attività anti-angiogenica, adatte alla somministrazione per via parenterale, orale o topica.
ITMI920057A 1992-01-15 1992-01-15 Impiego terapeutico del monosialodiesosil ganglioside gm3 e derivati come agenti anti-angiogenici IT1262929B (it)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITMI920057A IT1262929B (it) 1992-01-15 1992-01-15 Impiego terapeutico del monosialodiesosil ganglioside gm3 e derivati come agenti anti-angiogenici

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI920057A IT1262929B (it) 1992-01-15 1992-01-15 Impiego terapeutico del monosialodiesosil ganglioside gm3 e derivati come agenti anti-angiogenici

Publications (3)

Publication Number Publication Date
ITMI920057A0 ITMI920057A0 (it) 1992-01-15
ITMI920057A1 ITMI920057A1 (it) 1993-07-15
IT1262929B true IT1262929B (it) 1996-07-22

Family

ID=11361547

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI920057A IT1262929B (it) 1992-01-15 1992-01-15 Impiego terapeutico del monosialodiesosil ganglioside gm3 e derivati come agenti anti-angiogenici

Country Status (1)

Country Link
IT (1) IT1262929B (it)

Also Published As

Publication number Publication date
ITMI920057A1 (it) 1993-07-15
ITMI920057A0 (it) 1992-01-15

Similar Documents

Publication Publication Date Title
GEP20043324B (en) Purine Derivatives
AU591125B2 (en) Therapeutic nucleosides
HK1000913A1 (en) Use of indolone derivatives for the preparation of medicaments for the treatment of parkinsons disease
UA70298A (uk) Похідні с-4"-заміщених макролідів, спосіб їх одержання, проміжні сполуки, фармацевтична композиція та спосіб лікування бактеріальної інфекції або протозойної інфекції
EP0513702A3 (en) Melatonin derivaties for use in the therapy of sleep disorders and in pre-anaesthetic medication
DE69231522D1 (de) 1-substituierte-4-amino-1h-imidazo 4,5-c chinoline, zwischenprodukte und arzneimittel
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
AU1578688A (en) Pharmaceutical composition, for oral administration, designed to attenuate the effects of beta-lactamines
TW234691B (it)
ES2147788T3 (es) 3,4-diarilcromanos para el tratamiento de la dermatitis.
HUP0004282A2 (hu) 2-Halogén-6-0-szubsztituált ketolidszármazékok
EP0620004A4 (en) MEDICAL COMPOSITION.
AU1277792A (en) Compositions for topical administration containing fluticasone propionate and oxiconazole or its salts
ATE268174T1 (de) Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen
IT1229477B (it) Impiego di 5' deossi - 5' metiltioadenosina, s adenosilmetionina e dei loro sali per la preparazione di composizioni farmaceutiche atte a ridurre la seborrea e composizioni farmaceutiche relative
UA42733C2 (uk) Похідні біснафталіміду та їх фармацевтично прийнятні кислотно-адитивні солі, фармацевтична композиція з цитотоксичною активністю, яка їх містить
AU563762B2 (en) S-adenosyl-l-methionine salts preparation
ZA881053B (en) Prostaglandin e1 derivatives as pharmacologically active agents,and pharmaceutical compositions containing these compounds,especially for transcutaneous administration
GR890100833A (en) Process for the preparation of a compound with gastric inhibitopy effect
ES2037095T3 (es) Un procedimiento para preparar una composicion farmaceutica.
CA2078869A1 (en) Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
IT1262929B (it) Impiego terapeutico del monosialodiesosil ganglioside gm3 e derivati come agenti anti-angiogenici
AP9801235A0 (en) Erythromycin derivatives.
SE7708622L (sv) 2-bensyl-perhydroazepiner, sett for framstellning derav och lekemedel, innehallande dem
ES2169117T3 (es) Uso de derivados de 2-aminopurina en el tratamiento y profilaxis de la infeccion por el virus 7 del herpes humano.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970926